VRDN
Viridian Therapeutics, Inc.
$19.26
$1.73B
Price
$19.26
Market Cap
$1.73B
Revenue CAGR (5Y)
+39.5%
EPS CAGR (5Y)
-0.3%
Revenue Growth
Year over Year+31.5%
2016
+20.0%
2017
+109.5%
2018
-46.8%
2019
-76.5%
2020
+182.2%
2021
-40.2%
2022
-82.3%
2023
-3.8%
2024
+23359.9%
2025
EPS Growth
Year over Year+16.3%
2016
-17.6%
2017
+19.8%
2018
-22.6%
2019
-53.6%
2020
+78.7%
2021
+41.3%
2022
-35.8%
2023
+25.0%
2024
+16.6%
2025